Bright Minds Biosciences DRUG
NASDAQ DRUG
$23.45 +0.84 (+3.72%)
At close: Nov 11, 2026 · 4:00 PM EST

Bright Minds Biosciences (DRUG) Tax Provisions (2025)

Updated

Bright Minds Biosciences (DRUG) reported Tax Provisions of -$187,377 for fiscal Q4 2025 (quarter ended Sep 30, 2025).

Analysis

Bright Minds Biosciences (DRUG) Tax Provisions (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 1.96 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -176.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 609.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 492.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -842.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 822.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 634.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 134.00 Mn
10 Bright Minds Biosciences 172.65 Mn -390.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 186,107.28
API Access

Bright Minds Biosciences Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=DRUG&period=max&api_key=YOUR_API_KEY